Highlights in Asthmology
Editat de F. B. Michel, J. Bousquet, P. Godarden Limba Engleză Paperback – 17 noi 2011
Preț: 700.77 lei
Preț vechi: 737.65 lei
-5%
Puncte Express: 1051
Carte tipărită la comandă
Livrare economică 20 iulie-03 august
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9783642703188
ISBN-10: 3642703186
Pagini: 472
Ilustrații: XVI, 453 p.
Dimensiuni: 170 x 244 x 25 mm
Greutate: 0.74 kg
Ediția:Softcover reprint of the original 1st ed. 1987
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642703186
Pagini: 472
Ilustrații: XVI, 453 p.
Dimensiuni: 170 x 244 x 25 mm
Greutate: 0.74 kg
Ediția:Softcover reprint of the original 1st ed. 1987
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
A. Introduction.- 1. Preface.- 2. Natural History of Asthma.- B. Epidemiology.- 3. Epidemiology of Bronchial Asthma.- 4. Genetic Factors of Allergy.- 5. Changing Prevalence of Asthma in Developing Countries.- C. Etiology.- 6. Viruses.- 7. Allergic Bronchopulmonary Aspergillosis.- 8. Bacterial Asthma.- 9. Exercise-induced Asthma: Clinical Aspects.- 10. Asthma and Gastroesophageal Reflux.- D. Immunology.- 11. The IgE Receptors (Introduction).- 12. Immunological Mechanisms.- 13. Mechanisms of IgE-mediated Immediate Reactions.- 14. Properties of Short-term Sensitizing IgG Antibodies (IgG S-TS) in Asthma.- 15. The Role of Lymphocytes and of their Abnormalities in Atopic Diseases.- 16. Delayed-type Hypersensitivity Responses to Inhalant Allergens: a Form of Cutaneous Basophil Hypersensitivity (CBH).- E. Mediator Release and Bronchial Obstruction.- 17. Physiological and Pharmacological Control of Inflammatory Mediator Release in Bronchial Asthma.- 18. Mast Cells and Basophils.- 19. Alveolar Macrophages.- 20. Neutrophils and the Asthmatic Response.- 21. Eosinophils in Bronchial Asthma.- 22. Mediators of Asthma Derived from Arachidonic Acid.- 23. PAF-acether (Platelet Activating Factor).- 24. Immediate-type Reactions.- 25. Late Phase Reactions.- F. Bronchial Pathophysiology.- 26. Bronchi of Asthmatic Patients.- 27. The Site of Bronchial Obstruction in Asthma.- 28. Factors in Bronchial Hyperreactivity.- 29. Bronchial Hyperreactivity: Autonomie Nervous System Abnormalities.- 30. Bronchial Hyperresponsiveness and Asthma: Unanswered Questions.- G. Asthma due to Allergy Occupation, Food and Drugs.- 31. Preparation and Stability of Pollen Extracts.- 32. Allergen Standardization.- 33. Allergen Avoidance.- 34. Allergens Inducing Asthma (Introduction).- 35. Agricultural Asthma.- 36. Investigation of Occupational Asthma due to Low Molecular Weight Agents.- 37. Occupational Asthma.- 38. Food-related Asthma.- 39. Drug-induced Asthma.- H. Clinical Features and Diagnosis in Children and Adults.- 40. Clinical Aspects of Asthma.- 41. Asthma in Childhood.- 42. Diagnosis of Asthma in Childhood.- 43. Treatment of Childhood Asthma.- 44. Asthma in Adults.- 45. Skin Tests.- 46. Diagnostic Value of IgE in Bronchial Asthma.- 47. Pulmonary Function Tests in Asthma.- 48. Bronchial Provocation Tests.- 49. Status Asthmaticus.- I. Therapeutic Considerations.- 50. Physiopathological Data for the Treatment of Bronchial Asthma.- 51. Possible Therapeutic Developments.